FDA permits experimental use of Iplex on ALS patients

03/11/2009 | Reuters

The FDA said it is allowing selected patients with Lou Gehrig's disease to use Iplex, Insmed's treatment for growth-hormone deficiency, as the company awaits the conclusion of a patent-infringement case that put sales on hold. Insmed plans to use part of its "very limited" supply of Iplex to conduct safety trials.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Assistant General Counsel, Regulatory
Cardinal Health
Waukegan, IL
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Sr Manager, Business Conduct
Gilead Sciences
Foster City, CA
Chief Executive Officer
UCare Minnesota
Minneapolis, MN